Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating featuresChad J. Creighton, Jenny C. Chang, Xiaoxian Li et al.|Proceedings of the National Academy of Sciences|2009Cited by 1.4k
A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft ModelsXiaomei Zhang, Michael T. Lewis, Rachel Schiff et al.|Cancer Research|2013Cited by 485
Drug-repositioning screening identified piperlongumine as a direct STAT3 inhibitor with potent activity against breast cancerUddalak Bharadwaj, David J. Tweardy, T. Kris Eckols et al.|Oncogene|2014Cited by 159
Cancer stem cell markers are enriched in normal tissue adjacent to triple negative breast cancer and inversely correlated with DNA repair deficiencyRachel L. Atkinson, Jenny C. Chang, Wei Yang et al.|Breast Cancer Research|2013Cited by 71
A gene transcription signature of obesity in breast cancerChad J. Creighton, Jenny C. Chang, Yvonne H. Sada et al.|Breast Cancer Research and Treatment|2011Cited by 63